Smartleaf Asset Management’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
Other funds holding VIR
Smartleaf Asset Management's VIR Position: Q3 2026 in Review
Smartleaf Asset Management opened a new position in Vir Biotechnology (VIR) in Q3 2026: 179 shares worth $1.91K. The stake represents ﹤0.01% of the portfolio and ranks #3052 among its holdings. This is a return to the name: Smartleaf Asset Management previously reported a position in VIR as recently as Q1 2025.
Smartleaf Asset Management first reported a position in VIR in Q2 2024 and has held it in 5 quarters since. The position peaked at $3.88K in Q2 2024. 222 funds tracked by Wall St. Rank hold VIR as of Q3 2026.
- Smartleaf Asset Management held 179 shares of Vir Biotechnology worth $1.91K as of Q3 2026.
- Vir Biotechnology was a new Smartleaf Asset Management position in Q3 2026.
- Vir Biotechnology made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q3 2026, its #3052 holding.
- Smartleaf Asset Management first reported a position in Vir Biotechnology in Q2 2024 and has held it in 5 quarters since.
- Smartleaf Asset Management's Vir Biotechnology position peaked at $3.88K in Q2 2024.
- 222 funds tracked by Wall St. Rank held Vir Biotechnology as of Q3 2026.
Based on Smartleaf Asset Management's 13F filing for Q3 2026, filed 10 Nov 2026.